계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
SciNeuro
company
About
SciNeuro is a biotechnology company focused on developing innovative medicines for patients with central nervous system diseases.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $100M
- Industries
- Biopharma,Biotechnology,Neuroscience
- Founded date
- Jan 1, 2020
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$100M
SciNeuro has raised a total of
$100M
in funding over 2 rounds. Their latest funding was raised on
Dec 8, 2020 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 8, 2020 | Series A | $100M | 2 |
ARCH Venture Partners
Lilly Asia Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
SciNeuro is funded by 2 investors.
ARCH Venture Partners
and Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
ARCH Venture Partners
|
Yes | Series A |
|
Lilly Asia Ventures
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
